| Fuentes-Prior, Pablo; Salvesen, Guy S (2004) The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 384:201-32 |
| Boatright, Kelly M; Salvesen, Guy S (2003) Caspase activation. Biochem Soc Symp :233-42 |
| Boatright, Kelly M; Salvesen, Guy S (2003) Mechanisms of caspase activation. Curr Opin Cell Biol 15:725-31 |
| Turk, Boris; Turk, Dusan; Salvesen, Guy S (2002) Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des 8:1623-37 |
| Stennicke, Henning R; Ryan, Ciara A; Salvesen, Guy S (2002) Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem Sci 27:94-101 |
| Riedl, S J; Renatus, M; Snipas, S J et al. (2001) Mechanism-based inactivation of caspases by the apoptotic suppressor p35. Biochemistry 40:13274-80 |
| Snipas, S J; Stennicke, H R; Riedl, S et al. (2001) Inhibition of distant caspase homologues by natural caspase inhibitors. Biochem J 357:575-80 |
| Renatus, M; Zhou, Q; Stennicke, H R et al. (2000) Crystal structure of the apoptotic suppressor CrmA in its cleaved form. Structure 8:789-97 |
| Deveraux, Q L; Stennicke, H R; Salvesen, G S et al. (1999) Endogenous inhibitors of caspases. J Clin Immunol 19:388-98 |
| Stennicke, H R; Jurgensmeier, J M; Shin, H et al. (1998) Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273:27084-90 |
Showing the most recent 10 out of 18 publications
